Literature DB >> 9782237

Long-term complications following gamma knife radiosurgery of vestibular schwannomas.

G Norén1.   

Abstract

Since its inception in 1969, Gamma Knife radiosurgery (GKR) for vestibular schwannomas has been documented as an efficient and safe procedure based on more than 8,000 treatments worldwide. The author's personal experience comprises 669 treatments for patients with vestibular schwannoma between 1969-1997. This experience demonstrates long-term growth control, usually with shrinkage, in 95% of unilateral tumors. In the mid-1970s, early facial weakness occurred in 38% and facial numbness in 33%. This has gradually decreased to less than 2% in the 1990s. Preservation of hearing (unchanged or almost unchanged) is currently achieved in 65 to 70%. Tinnitus is rarely changed by the treatment. The risks of intracranial bleeding, infection and CSF leak are avoided because of the noninvasive nature of the treatment. Hydrocephalus directly induced by the tumor occurred in 9.2% of patients. On the other hand, a treatment%related peritumoral reaction sufficient to block the CSF circulation and require shunt insertion was seen in only 1.4%. Based on experiences worldwide, the incidence of secondary neoplasia seems to be 0.1%. The effectiveness of GKR together with its low complication rate makes it a suitable treatment for anyone, regardless of age and general health. With few exceptions, schwannomas with an intracranial size of up to approximately 3 cm are suitable for GKR.

Entities:  

Mesh:

Year:  1998        PMID: 9782237     DOI: 10.1159/000056408

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  20 in total

1.  On "malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery" (skull base 2010;20:381-388).

Authors:  Sami Tanbouzi Husseini; Enrico Piccirillo; Mario Sanna
Journal:  Skull Base       Date:  2011-03

Review 2.  Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

Authors:  D G R Evans; J M Birch; R T Ramsden; S Sharif; M E Baser
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

Review 3.  Intracranial applications of magnetic resonance-guided focused ultrasound.

Authors:  Nir Lipsman; Todd G Mainprize; Michael L Schwartz; Kullervo Hynynen; Andres M Lozano
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

4.  Malignant peripheral nerve sheath tumor at the cerebellopontine angle treated with Gamma Knife radiosurgery: case report and review of the literature.

Authors:  Daniel M S Raper; Fadi Sweiss; M Isabel Almira-Suarez; Gregory Helm; Jason P Sheehan
Journal:  J Radiosurg SBRT       Date:  2013

5.  Prevalence of hydrocephalus in 157 patients with vestibular schwannoma.

Authors:  Jeffrey M Rogg; S H Ahn; G A Tung; S E Reinert; G Norén
Journal:  Neuroradiology       Date:  2005-05-11       Impact factor: 2.804

Review 6.  The changing role of stereotaxis in surgical neuro-oncology.

Authors:  Mark E Linskey
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

7.  Management of acoustic neuroma in the only hearing ear.

Authors:  Maged B Naguib; Yasar Cokkeser; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-30       Impact factor: 2.503

8.  Long-term Outcomes of Gamma Knife Stereotactic Radiosurgery of Vestibular Schwannomas.

Authors:  Kang-Min Kim; Chul-Kee Park; Hyun-Tai Chung; Sun Ha Paek; Hee-Won Jung; Dong Gyu Kim
Journal:  J Korean Neurosurg Soc       Date:  2007-10-20

Review 9.  Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery.

Authors:  Isaac Yang; Michael E Sughrue; Seunggu J Han; Shanna Fang; Derick Aranda; Steven W Cheung; Lawrence H Pitts; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

10.  Therapeutic profile of single-fraction radiosurgery of vestibular schwannoma: unrelated malignancy predicts tumor control.

Authors:  Berndt Wowra; Alexander Muacevic; Christoph Fürweger; Christian Schichor; Jörg-Christian Tonn
Journal:  Neuro Oncol       Date:  2012-05-03       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.